Tag: TriSalus
TriSalus releases real-world data showing success for pressure-enabled drug delivery
TriSalus Life Sciences, an oncology company integrating delivery technology with immunotherapy in the treatment of patients with liver and pancreatic tumours, today announced the...
TriSalus presents preclinical data on proprietary infusion technology at SIR 2022
TriSalus’ clinical leadership team presented new preclinical data at the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting (11–16 June, Boston, USA). The...
New TriNav infusion system launches to overcome infusion barriers within solid...
TriSalus Life Sciences (“TriSalus”, formerly Surefire Medical) today announced the launch of its TriNav infusion system (“TriNav”). Powered by its proprietary pressure-enabled drug delivery...
